@onclive.bsky.social📰 The @fda.gov has granted priority review to elinzanetant for the treatment of moderate-to-severe vasomotor symptoms in patients receiving endocrine therapy for the management or prevention of HR+ breast cancer. #bcsm #oncology
Read more ➡️: www.onclive.com/view/fda-gra...
@vanjohn10.bsky.socialZacks' Senior Life Sciences Analyst John Vandermosten initiates on #ActiniumPharmaceuticals with a $4.00 price target.
youtube.com/shorts/Gh-GB...
Initiation: tinyurl.com/bdj6rjtm
$ATNM #NuclearMedicine #Radiopharmaceuticals #Oncology #AML #TargetedRadiotherapy #Biotech #CancerResearch
@onclive.bsky.social🇨🇳China's NMPA has approved of pirtobrutinib in treatment-naive and previously treated CLL/SLL, based on the phase 3 BRUIN CLL-313 and BRUIN CLL-314 trials.
Full details 💥: onclive.com/view/china-s...
@onclive.bsky.social🎙️On this episode of #OncLiveOnAir Philip A. Philip, MD, of @henryfordhealth.bsky.social discusses TTFields in pancreatic cancer and what phase 3 data has shown in locally advanced disease.
Listen here ➡️: www.onclive.com/view/explori...
@onclive.bsky.social[email protected] recognized members of its clinical, research and healthcare teams during the second annual Excellence Awards. #oncology
Read more: www.onclive.com/view/roswell...
@gmj-georgia.bsky.social🔬 A new investigational targeted therapy combined with standard chemotherapy has shown promise in advanced pancreatic cancer, according to early data … #Biomarkerdriventreatment #ESMO2026 #Oncology #Pancreaticcancer #Targetedtherapy #Biomarkerdriventreatment #ESMO2026 #Oncology #Pancreaticcance…
@bcc2026.bsky.socialBreast Cancer Congress 2027
Join experts, researchers, clinicians & innovators for two days of scientific exchange and collaboration.
June 17–18, 2027
Zurich, Switzerland
Online participation available
#BreastCancer #Oncology #CancerResearch #BreastCancerCongress #BCC2027
@newsen.bsky.socialGrowth of KRAS Inhibitor Market Forecasted to Hit $7.8 Billion by 2034 #United_States #San_Diego #oncology #KRAS_Inhibitors #Biotech_Sector
@fgbonadonna.bsky.socialAdding belzutifan to adjuvant pembrolizumab improves disease-free survival but increases adverse events in resected clear-cell renal cell carcinoma at increased risk for recurrence
fondazionebonadonna.org/en/pembroliz...
#FondazioneBonadonna #Oncology #CancerResearch
@newsen.bsky.socialDr. Michael White Promoted to President of Research and Development at IDEAYA Biosciences #USA #oncology #IDEAYA_Biosciences #South_San_Francisco #Dr._Michael_White
@cancers-mdpi.bsky.social🌟We are delighted to share some highly cited #SpecialIssues in 2025 related to "Cancer Therapy" in Cancers (ISSN 2072-6694)!
🔎Explore them at the link: www.mdpi.com/journal/canc...
@currentmedscience.bsky.social#mRNAVaccines hold promise in #Oncology.
This review highlights RNA design, lipid nanoparticle delivery, antigen encoding, and immunomodulators as strategies to overcome TME barriers in cancer #immunotherapy. #medsky
To read: doi.org/10.1007/s115...
@targetedonc.bsky.social📢 ICYMI: The #FDA has approved lirafugratinib (Lyrfigtu) for adults with previously treated unresectable, locally advanced or metastatic #cholangiocarcinoma harboring an FGFR2 gene fusion or other rearrangement.
Read more: targetedonc.com/view/fda-app...
@currentmedscience.bsky.socialBy analyzing #CD8+, CD4+, NKT, and γδ T cells, this study underscores the promise of TCR‑T, #CART, and checkpoint inhibitors in achieving long‑term AML control and advancing future therapeutic strategies. #medsky
To read: doi.org/10.1007/s115...
@bcc2026.bsky.socialBreast Cancer Congress 2027
Join researchers, healthcare professionals, and experts for two days of knowledge sharing and collaboration.
June 17–18, 2027
Zurich, Switzerland
pinkribboncongress.com/registrations/
#BreastCancer #CancerResearch #Oncology #Healthcare #MedicalConferenc #BCC2027
@meducationai.bsky.socialStuck on a patient question in clinic with no one around to ask? Specialist AI agents take your de-identified case and report back from each point of view. Free with OncoPulse.
@nextlogic-ai.bsky.social🎨 New Post: Hope for Pancreatic Cancer: New Drug Darzanbrasib Offers Extended Survival
#ai #genomics #oncology #TechNews #GlobalMedia
👇 View Full Illustration:
https://nextlogic-ai.achlabo.com/en/hope-for-pancreatic-cancer-new-drug-darzanbrasib-offers-extended-survival/
@fennecpharma.com#Ovarian & #Gynecologic cancers affect 100K+ US women every year but remain among the most under-researched & underfunded in #oncology. This #GynecologicCancerAwarenessMonth, we stand with the community to demand better outcomes.
#OncSky